tiprankstipranks
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market

AbCellera Biologics (ABCL) Income Statement

Compare
1,685 Followers

AbCellera Biologics Income Statement

Last quarter (Q3 2024), AbCellera Biologics's total revenue was $6.51M, a decrease of -1.39% from the same quarter last year. In Q3, AbCellera Biologics's net income was $-51.11M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 38.02M$ 485.42M$ 375.20M$ 233.16M$ 11.61M
Gross Profit
$ 38.02M$ 418.99M$ 329.69M$ 206.01M$ 1.50M
Operating Expenses
$ 275.23M$ 191.92M$ 107.79M$ 41.66M$ 13.95M
Depreciation and Amortization
$ 30.89M$ 33.10M$ 17.25M$ 5.27M$ 1.60M
EBITDA
$ -192.16M$ 272.20M$ 241.62M$ 169.62M$ -397.42K
Operating Income
$ -237.21M$ 216.51M$ 204.41M$ 156.03M$ -4.12M
Other Income/Expenses
$ 63.18M$ 22.59M$ 14.74M$ 1.80M$ 1.91M
Pretax Income
$ -174.03M$ 239.10M$ 219.15M$ 157.83M$ -2.21M
Net Income
$ -146.40M$ 158.52M$ 153.46M$ 118.92M$ -2.42M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.51$ 0.56$ 0.56$ 0.44$ -0.02
Diluted EPS
$ -0.51$ 0.50$ 0.48$ 0.44$ -0.02
Weighted Average Shares Outstanding
289.17M 285.06M 275.76M 269.50M 154.09M
Weighted Average Shares Outstanding (Diluted)
289.17M 314.83M 318.29M 269.50M 154.09M
Currency in USD

AbCellera Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis